Overview

PET Imaging of Brain Amyloid Using [11C]MeS-IMPY

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Alzheimer's disease is associated with accumulation in the brain of a protein called amyloid. The purpose of this study is to test the ability of a research drug to measure amyloid in brain using positron emission tomography (PET) and a research drug called [11C]MeS-IMPY.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Mental Health (NIMH)